The development of a quality of life instrument specific to treatment effects in autoimmune bullous disease

Not Applicable

Completed

• Conditions: Quality of Life in Autoimmune Bullous Disease; Skin - Dermatological conditions; Inflammatory and Immune System - Autoimmune diseases

• Registration Number: ACTRN12613000365763
• Lead Sponsor: Australasian Blistering Diseases Foundation

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-04-05
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Clinically and histologically diagnosed autoimmune bullous disease

Exclusion Criteria

Limited fluency in English

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The development of a quality of life instrument specific to autoimmune bullous disease. Once this instrument has been developed and if it is found to be statistically sound, it will be used by other researchers when evaluating treatment based quality of life in patients with blistering diseases.[Patient recruitment will cease once approximately 70 patients have been recruited and have completed the pilot questionnaire. This will mark the end of the patient recruitment process and occur at the end of the trial period. Once this target has been reached, statistical review of the results will be completed]

Secondary Outcome Measures

Name	Time	Method
il[Nil]